This inventor holds 4 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Denovo Biopharma LLC, Tocagen Inc.. Active years: 2017-2022.
Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Derek G Ostertag
Introduction
Derek G Ostertag is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant vectors and retroviral vectors. With a total of 4 patents, his work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
One of his latest patents is titled "Recombinant vectors comprising 2A peptide." This disclosure provides modified recombinant retroviruses containing a 2A-peptide or peptide-like coding sequence operably linked to a heterologous polynucleotide. The disclosure further relates to cells and vectors expressing or comprising such vectors and methods of using these modified vectors in the treatment of disease and disorders. Another significant patent is "Retroviral vector having immune-stimulating activity." This disclosure provides vectors for treating cancers, methods of producing such vectors, and methods of using the vectors.
Career Highlights
Derek has worked with notable companies in the biotechnology sector, including Tocagen Inc. and Denovo Biopharma LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his coworkers include Douglas J Jolly and Amy Lin. Their collaborative efforts have further advanced the research and development of innovative biotechnological solutions.
Conclusion
Derek G Ostertag's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.